DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation.

Doris Lambracht-Washington, Bao Xi Qu, Min Fu, Larry D. Anderson, Olaf Stüve, Todd N. Eagar, Roger N. Rosenberg

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation.'. Together they form a unique fingerprint.

Medicine & Life Sciences